# Iron Orotate Tetrahydrate

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/iron-orotate-tetrahydrate
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Ferrous Orotate Tetrahydrate, Iron(II) Orotate Tetrahydrate, Fe Orotate·4H2O, Iron Bis-orotate Tetrahydrate, Ferrous Orotate Complex, Iron Orotate Hydrate, Bis(orotato)iron(II) Tetrahydrate

## Overview

Iron orotate tetrahydrate is a chelated iron compound in which ferrous iron is bound to orotic acid in a tetrahydrate crystal form, providing approximately 13.0–13.8% elemental ferrous iron by weight. It belongs to the orotate mineral salt class theorized to enhance membrane transport via orotic acid's affinity for cellular uptake pathways, though no human clinical trials have confirmed efficacy or superiority over other iron forms.

## Health Benefits

• No clinically proven health benefits - no human trials documented in available research
• Functions as an iron supplement source providing 13.0-13.8% ferrous iron content
• No evidence of specific advantages over other iron forms in humans
• Animal toxicity data exists but no efficacy studies available
• Theoretical use for iron deficiency requires clinical validation

## Mechanism of Action

Iron orotate tetrahydrate dissociates in the gastrointestinal tract to release ferrous iron (Fe²⁺) and orotic acid (uracil-4-carboxylic acid). Ferrous iron is absorbed primarily via the divalent metal transporter 1 (DMT1) in duodenal enterocytes, where it enters systemic circulation and binds to transferrin for delivery to tissues requiring iron-dependent enzymes such as hemoglobin, myoglobin, and cytochromes. The orotic acid moiety is theorized by proponents to facilitate passive diffusion across lipid membranes, potentially improving intracellular iron delivery, but this mechanism has not been validated in controlled human pharmacokinetic studies.

## Clinical Summary

No published human clinical trials investigating iron orotate tetrahydrate for efficacy, bioavailability, or therapeutic outcomes could be identified in available research literature. Existing data is limited to animal toxicity studies, which characterize safety thresholds rather than therapeutic benefit. Without randomized controlled trials, sample size data, or quantified clinical endpoints in humans, no evidence-based conclusions can be drawn about its effectiveness for iron deficiency anemia or any other condition. The evidence base is therefore rated extremely low, and clinical use should be guided by better-studied iron forms such as ferrous sulfate or ferrous bisglycinate.

## Nutritional Profile

Iron Orotate Tetrahydrate is a chelated mineral compound consisting of ferrous iron (Fe²⁺) bound to orotic acid (vitamin B13 precursor) with four water molecules of crystallization. Iron content: 13.0–13.8% elemental ferrous iron by molecular weight, derived from its molecular formula FeC₅H₄N₂O₄·4H₂O (molecular weight approximately 404 g/mol). Contains no macronutrients (zero protein, fat, or carbohydrate contribution at supplemental doses). Orotic acid component (C₅H₄N₂O₄) constitutes approximately 60–62% of the anhydrous compound by mass and is a pyrimidine precursor involved in nucleotide biosynthesis pathways. No dietary fiber, vitamins, or secondary micronutrients present. Bioavailability: ferrous (Fe²⁺) oxidation state is the more bioavailable form of iron compared to ferric (Fe³⁺); the orotate chelation is theorized to enhance mucosal transport by protecting iron from precipitation in alkaline intestinal environments, though this mechanism has not been confirmed in human clinical trials. The tetrahydrate form releases water of crystallization upon dissolution, yielding the active iron orotate complex. No documented comparative bioavailability data versus ferrous sulfate, ferrous bisglycinate, or other standard iron supplement forms in humans. At typical supplemental iron doses (18–65 mg elemental iron), a serving would require approximately 130–500 mg of the tetrahydrate compound based on its 13–13.8% iron content.

## Dosage & Preparation

No clinically studied dosage ranges are available as no human trials have been documented. Commercial forms contain 13.0-13.8% ferrous iron content. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Because no dedicated human safety trials exist for iron orotate tetrahydrate, its side effect profile is inferred from the broader class of oral iron supplements, which commonly cause gastrointestinal adverse effects including nausea, constipation, and dark stools, particularly at doses exceeding 45 mg elemental iron per day. Orotic acid, the chelating ligand, has been independently associated with hepatic lipid accumulation and orotic aciduria in animal models at high doses, raising a theoretical concern not yet evaluated in humans. Iron supplements broadly interact with tetracycline and quinolone antibiotics, levothyroxine, and calcium-containing products by forming insoluble complexes that reduce absorption of both the drug and the iron. Pregnancy safety has not been specifically evaluated for this compound; standard supplemental iron is considered safe in pregnancy under medical supervision, but iron orotate tetrahydrate should not be substituted without clinical guidance.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses for Iron Orotate Tetrahydrate were found in the research sources. Limited data exists only from animal toxicity studies with no PMIDs or specific study details available.

## Historical & Cultural Context

No historical or traditional medicinal uses are documented for Iron Orotate Tetrahydrate. It is described solely as a modern dietary supplement ingredient with no traditional medicine heritage.

## Synergistic Combinations

Vitamin C, Vitamin B12, Folate, Copper, Vitamin A

## Frequently Asked Questions

### How much elemental iron does iron orotate tetrahydrate contain?

Iron orotate tetrahydrate provides approximately 13.0–13.8% elemental ferrous iron (Fe²⁺) by molecular weight. This is considerably lower than ferrous sulfate heptahydrate (~20% elemental iron) or ferrous bisglycinate (~20%), meaning larger doses of the compound are required to deliver equivalent elemental iron. Formulation labels should always be checked for the actual milligrams of elemental iron per serving rather than the total compound weight.

### Is iron orotate tetrahydrate better absorbed than ferrous sulfate?

There are no published human pharmacokinetic or bioavailability studies directly comparing iron orotate tetrahydrate to ferrous sulfate or any other iron form. Proponents suggest that orotic acid may enhance membrane permeability to improve intracellular iron delivery, but this hypothesis is unverified in clinical research. Until comparative absorption data exists, ferrous bisglycinate and ferrous sulfate remain the better-evidenced choices for iron supplementation.

### What is iron orotate tetrahydrate used for?

Iron orotate tetrahydrate is marketed as a dietary supplement intended to provide a source of supplemental ferrous iron, theoretically for addressing or preventing iron deficiency. Iron itself is essential for hemoglobin synthesis, electron transport chain function via cytochromes, and myoglobin oxygen storage. However, no clinical evidence currently supports specific therapeutic indications unique to this particular compound form compared to other iron salts.

### Are there any side effects of taking iron orotate tetrahydrate?

No dedicated human adverse-event studies exist for iron orotate tetrahydrate specifically. Based on the general iron supplement class, expected side effects include constipation, nausea, epigastric discomfort, and black-colored stools, which are dose-dependent and more pronounced above 45 mg of elemental iron per day. Additionally, orotic acid at high doses has shown hepatotoxic and lipid-accumulating effects in animal models, representing a theoretical risk that has not been assessed in human trials.

### Can iron orotate tetrahydrate interact with medications?

Like all oral iron salts, iron orotate tetrahydrate is expected to form insoluble complexes with tetracycline and fluoroquinolone antibiotics (e.g., ciprofloxacin), levothyroxine, and bisphosphonates, significantly reducing the absorption of both the drug and iron when taken simultaneously. Calcium carbonate and antacids can raise gastric pH above the optimal range for ferrous iron solubility, further impairing absorption. To minimize interactions, iron supplements are generally recommended to be taken at least two hours apart from these medications.

### What is the difference between iron orotate tetrahydrate and other iron chelate forms?

Iron orotate tetrahydrate is a chelated iron form where ferrous iron is bound to orotic acid, which theoretically may enhance absorption compared to non-chelated salts like ferrous sulfate. However, human clinical trials comparing iron orotate tetrahydrate directly to other chelate forms (such as iron glycinate or iron bisglycinate) have not been published, making definitive superiority claims unsupported by evidence. The tetrahydrate designation indicates the presence of four water molecules in the crystal structure, which may affect stability and dissolution characteristics. Without human efficacy studies, the practical advantage of this specific chelate form over alternatives remains unproven.

### Who should avoid taking iron orotate tetrahydrate supplements?

Individuals with hemochromatosis or other iron overload disorders should avoid iron orotate tetrahydrate due to the risk of excessive iron accumulation. People with active gastrointestinal inflammation, ulcers, or inflammatory bowel disease should consult a healthcare provider before supplementation, as iron can exacerbate GI symptoms. Those taking certain medications that strongly interact with iron absorption or those with kidney disease should seek medical guidance before use. Additionally, individuals without documented iron deficiency should avoid supplementation, as excess iron can generate oxidative stress and cause tissue damage.

### What does research show about the effectiveness of iron orotate tetrahydrate in treating iron deficiency?

No published human clinical trials have evaluated the efficacy of iron orotate tetrahydrate for treating or preventing iron deficiency anemia. While animal toxicity studies exist, these do not demonstrate clinical effectiveness in humans. The ingredient functions as a source of ferrous iron (approximately 13.0-13.8% elemental content), but without human trials, claims about its superiority for iron repletion remain theoretical. Any therapeutic use for iron deficiency would require clinical validation through properly designed human studies before efficacy can be established.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*